Biotest (stand 74)
Biotest is a developing pharma and biotherapeutical company headquartered in Germany, which is specialised in immunology and haematology.
Biotest produces and distributes worldwide plasmaproteins, for the treatment of diseases of the immune or heamatopoetic systems.
As world market leader in hyperimmunoglobulins and exclusive manufacturer of IgM-enriched immunoglobulins, Biotest considers itself as a provider of special solutions for the prevention and therapy of life-threatening and rare infections.
Biotest does research in monoclonal antibodies for the therapy of autoimmune diseases. For haemophilia A- and B-therapy, Biotest offers a modern stock of plasmatic factor products. Biotest employs more than 1,600 people worldwide. The preference shares of the Biotest AG are listed at the SDAX of Deutsche Börse AG.
